Adherence and persistence in patients with postmenopausal osteoporosis treated with raloxifene.

@article{Ziller2011AdherenceAP,
  title={Adherence and persistence in patients with postmenopausal osteoporosis treated with raloxifene.},
  author={Volker Hagen Ziller and Katrin Wetzel and Ioannis Kyvernitakis and Berna Seker-Pektas and P. Pevman Hadji},
  journal={Climacteric : the journal of the International Menopause Society},
  year={2011},
  volume={14 2},
  pages={
          228-35
        }
}
OBJECTIVE A major impediment in osteoporosis care is poor therapeutic adherence. Real-life surveys show that adherence and persistence with oral bisphosphonates decrease to 30-60% within 1 year. The aim of this study was to analyze the adherence and persistence with raloxifene in patients visiting our outpatient clinic. MATERIAL AND METHODS A total of 342 patients were evaluated from the conventional osteoporosis practice receiving treatment with raloxifene. Patient self-reporting was… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Similar Papers

Loading similar papers…